Health
Results: 1597-1608 of 6447

Sectra's nine-month interim report 2024/2025: The industry's most satisfied customers for the twelfth consecutive year

New BRAVO Study Publication Reinforces Clinical Benefits of BLC in Reducing Risk of Bladder Cancer Recurrence

Galderma Successfully Placed an Inaugural EUR 500 Million Single Tranche Eurobond and New Dual Tranche CHF 435 Million CHF Bonds
